BJefferson

Nashville Interventional Cardiologist

[Westby Fisher, MD @doctorwes]

Brilliant exposé on ABMS lobbying tactics used to maintain their MOC monopoly and mislead the public https://t.co/T3GJCVygJ3 @InfoNbpas @ABMSCert

[BJefferson @mobitz]

@CMichaelGibson https://t.co/qKklCdBRyX

[Westby Fisher, MD @doctorwes]

This 👇

[National Board of Physicians and Surgeons @InfoNbpas]

BREAKING NEWS: WSJ just published an op-ed by Dr. Paul Teirstein on how the current board certification monopoly is driving physicians out of medicine. It’s time for change!
⁦@WSJ⁩ ⁦@HHSGov⁩ ⁦@FTC⁩ ⁦@TheJusticeDept⁩ https://t.co/lAzZKgjCwX

[BJefferson @mobitz]

@laurarowe95 @byEliHoff Needs a GoFundMe

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis: @JACCJournals

🥸 on drug coated balloons.

👇👇👇

[Shockwave Medical @ShockwaveIVL]

Congratulations to Dr Brian Jefferson and the team at Tristar HCA Hospital in Nashville, TN for performing the 1st two cases worldwide with the new Shockwave CS Guide Catheter! The two single arm cases were performed as part of the COSIRA II trial and the new guide catheter delivered improved performance and useability by being Shockwave's first guide catheter designed specifically for the coronary venous system.

To learn more about the COSIRA-II trial and the participating sites visit  https://t.co/TAt8wltR9Q 

ISI  https://t.co/x46wohk9Gd  Caution: Reducer System is an Investigational Device. Limited by U.S. and Canadian law to investigational use.

[BostonSci Cardiology @BSCCardiology]

The FRACTURE IDE Trial aims to assess the safety and efficacy of a novel intravascular lithotripsy system by BOLT Medical in patients undergoing PCI for the treatment of coronary artery disease with severely calcified lesions.

Dr. Brian K. Jefferson (@mobitz), a physician at TriStar Centennial Medical Center, and investigator with the @HCAhealthcare Research Institute, performed the first U.S. procedures, officially initiating enrollment at U.S. sites for the FRACTURE IDE trial.

Learn more: https://t.co/AooT8Fh3LZ

CAUTION: Investigational device. Limited by US law to investigational use only. Not available for sale.

[BJefferson @mobitz]

@NSC_Stats Agree. Feel like we are ahead of where we expected and could even improve quite a bit with the current squad and even more with some smart moves. 🤞

[Westby Fisher, MD @doctorwes]

* BREAKING* ABIM loses copyright infringement case against Dr. Jaime Salas-Rushford AND loses effort to seal opinion. Depositions, tactics, ABIM attorney insults, secret agreements: entire docket. All public now. https://t.co/RMOiuuJQ1b https://t.co/zqKjkx0AMb

[Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI @DrJayMohan]

1/ Renal Denervation- which system works?

The two main players in the space are ultrasound guided (@ReCorMedical Paradise) and radio frequency (@MedtronicCRDN Simplicity).

When starting a new program how do you choose? Let’s review

#RDN #CardioX #NephroX #NoCOI

[Alex Truesdell @agtruesdell]

Lots of (appropriate) renewed “buzz” about IVI 👁️with publication of recent 2024/2025 ESC and ACC/SCAI guidelines. If you’re not imaging pre-, intra-, and post-PCI: why not? If your Cath Lab doesn’t support IVI 👁️: why not?…

[Michael Megaly @MichaelMegalyMD]

This year I am late in #my_4_slides on my most important takeaways from #CTO2025

Lots of great stuff and I will start with the intriguing #CTO #PCI techniques I will try in 2025.

1-HDR presentation by @realarainmd
He explains it perfectly, his cases on X are enjoyable.

In a very simple way
1-Stick the cap (a few mm)
2-Advance MC- pull wire while dripping contrast (prevent air trapping in the MC)
3-Inject slowly <0.5 cc
4-Analyze and decide next steps

If intraplaque staining, nontip Fielder XT. If extraplaque, move down your algorithm (stick again or use other techniques)
#cardioX #accfit

[BJefferson @mobitz]

@chadinabhan @VincentRK @AaronGoodman33 @Rfonsi1 Support @doctorwes crowd funding, join @InfoNbpas use your @tnmed state med association to locally lobby, and your hospital MEC to change bylaws to recognize alternative certification. Worked in Tennessee

[Westby Fisher, MD @doctorwes]

@VincentRK @AaronGoodman33 @chadinabhan @Rfonsi1 When MOC becomes necessary for maintaining licensure, the ballgame’s over and states will lose their autonomy to regulate physicians. Fortunately, the Supreme Court has already seen through @TheFSMB agenda for nationwide regulation of dentists https://t.co/I3qSChHroF

[Westby Fisher, MD @doctorwes]

@CMichaelGibson Been there, done that. Silly to think cardiologists can do a better job than cardiologists already have (like @InfoNbpas ). Anything else is corrupt. Prove me wrong.

[BJefferson @mobitz]

Support @InfoNbpas

[C. Michael Gibson MD @CMichaelGibson]

Should professional societies lead the creation of a new cardiovascular board or should it be spearheaded by a new group ?

[Ian C Gilchrist Sr @Radial_ICG]

Board system is broken....Request for an American Board of Cardiovascular Medicine denied—cardiology groups ‘deeply disappointed’ https://t.co/I1Jn0JfqUD

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

This is such sad news.
I think we all wanted @ACCinTouch to take over our certification in #cardiology &amp; not leave to the ABMS.
Cardiology is often a Department, not within a Division of Medicine. We need to separate to make this happen.
😢😢😢 #CardioTwitter